Factors Associated with Treatment Outcomes in Mindfulness-Based Cognitive Therapy for Panic Disorder.
10.3349/ymj.2013.54.6.1454
- Author:
Borah KIM
1
;
Sung Joon CHO
;
Kang Soo LEE
;
Jun Yeob LEE
;
Ah Young CHOE
;
Ji Eun LEE
;
Tai Kiu CHOI
;
Sang Hyuk LEE
Author Information
1. Department of Psychiatry, CHA Bundang Medical Center, CHA University, Seongnam, Korea. leesanghyuk@yahoo.com
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
Mindfulness-Based Cognitive Therapy;
panic disorder;
treatment outcome;
anxiety sensitivity;
comorbid personality disorder
- MeSH:
Adult;
Cognitive Therapy/*methods;
Female;
Humans;
Male;
Middle Aged;
Mindfulness/*methods;
Panic Disorder/*therapy;
Socioeconomic Factors;
Young Adult
- From:Yonsei Medical Journal
2013;54(6):1454-1462
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Although the effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) for panic disorder (PD) has been studied previously, data on the predictors of treatment outcomes in MBCT for PD are scarce. MATERIALS AND METHODS: Eighty patients with PD were screened to analyze treatment outcomes such as MBCT completion, treatment response, and remission after undergoing MBCT for PD. Sociodemographic characteristics, comorbid personality disorders, and baseline medication doses were examined. The study administered the Panic Disorder Severity Scale, Hamilton Anxiety Rating Scale, Hamilton Depression Rating Scale and Anxiety Sensitivity Inventory-Revised to patients at baseline and at eight weeks. RESULTS: Sixty-five participants were enrolled in the present study. Comorbid personality disorder was significantly associated with MBCT non-completion. We found that anxiety sensitivity (AS) improvement after an eight week MBCT program was a statistically significant factor associated with treatment response. Using logistic regression analysis, AS improvement after MBCT showed significant association with PD remission after MBCT. CONCLUSION: Comorbid personality disorders of participants could be a potential predictor of MBCT non-completion. Furthermore, AS improvement after MBCT may predict treatment response and remission after MBCT for PD. However, better designed studies with a larger number of patients are needed to confirm our findings.
